Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/1995
05/10/1995EP0651749A1 Imidazole, triazole and tetrazole derivatives
05/10/1995EP0651745A1 New pyridine derivatives as leukcotriene b 4? antagonists
05/10/1995EP0651743A1 Indolinyl n-hydroxyurea and n-hydroxamic acid derivatives as lipoxygenase inhibitors
05/10/1995EP0651740A1 Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumours
05/10/1995EP0651738A1 Natural amino acid derivatives as metalloproteinase inhibitors
05/10/1995EP0651654A1 Lysozyme dimer and compositions containing the same
05/10/1995EP0651641A1 Novel bioactive compositions, preparation and use thereof
05/10/1995EP0651636A1 Chemotherapy for cancer
05/10/1995EP0607346A4 Collagen constructs.
05/10/1995CN1102324A Pharmaceutical composition
05/10/1995CN1028367C Nonsaditive antihistaminics derived from benzimidazoles
05/10/1995CA2135227A1 Method for preventing hair loss and stimulating new hair growth
05/09/1995US5414012 Indalyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
05/09/1995US5414009 Azabicyclo substituted oxa- or thia-diazole compounds
05/09/1995US5414008 Imidazolyl-substituted phenylpropionic and cinnamic acid derivatives
05/09/1995US5413998 Benzo-fused thiazopinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/09/1995US5413996 Targeted drug delivery via phosphonate derivatives
05/09/1995US5413991 Chitinase inhibitors; fungicides, insecticides
05/09/1995US5413791 Collagen-polymer conjugates
05/06/1995CA2135123A1 Medicine for preventing and curing bone fracture
05/06/1995CA2135000A1 Isoquinolines
05/04/1995WO1995011988A1 Compounds with pth activity and recombinant dna vectors encoding same
05/04/1995WO1995011914A1 Δ16 unsaturated c¿17? heterocyclic steroids useful as steroid c17-20 lyase inhibitors
05/04/1995WO1995011904A1 Novel a1 adenosine receptor agonists and antiagonists
05/04/1995WO1995011903A1 Tricyclic compounds having affinity for the 5-ht1a receptor
05/04/1995WO1995011885A1 Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands
05/04/1995WO1995011883A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation
05/04/1995WO1995011702A1 Prokaryotic expression of mhc proteins
05/04/1995WO1995011694A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same
05/04/1995WO1995011693A1 Hemoregulatory peptides
05/04/1995WO1994028132A3 Opioid receptors: compositions and methods
05/04/1995CA2175089A1 Prokaryotic expression of mhc proteins
05/04/1995CA2174850A1 Tricyclic compounds having affinity for the 5-ht1a receptor
05/04/1995CA2170736A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation
05/04/1995CA2134950A1 Method and compositions for stimulating intracellular glutathione
05/03/1995EP0650964A1 1 2H-1-benzopyran-2-one-8-yl -piperazine derivatives
05/03/1995EP0650961A1 Substituted heterocyclic carboxylic acid amides, their preparation, and their use as medicaments
05/03/1995EP0650960A1 Substituted heterocyclic carboxylic acid amide esters, their preparation and their us as medicaments
05/03/1995EP0650725A1 Compositions containing salts of L-2-oxothiazolidine-4-carboxylic acid and their use for stimulating intracellular glutathione
05/03/1995EP0650522A1 Novel cyclophilins, associating proteins and uses
05/03/1995EP0650485A1 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders
05/03/1995EP0650484A1 Endothelin receptor antagonists
05/03/1995EP0650480A1 1-arylsulphonyl, arylcarbonyl and 1-arylphosphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines
05/03/1995EP0650475A1 4-amino-n --(4-methyl-4-piperidinyl)-2-methoxybenzamides
05/03/1995EP0650374A1 Use of a calcium carbonate based porous material as support for a growth factor in the preparation of a bioabsorbable implant
05/03/1995EP0650368A1 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity
05/03/1995EP0650366A1 Compositions and methods for treating wounds
05/03/1995EP0650361A1 Compositions for the treatment of arthritis containing phosphonates and nsaids
05/03/1995EP0569541B1 Growth factor containing matrix for the treatment of cartilage lesions
05/03/1995EP0541594B1 Cyclopentane derivatives, process for producing them and their pharmaceutical use
05/03/1995EP0379522B1 Uses of recombinant colony stimulating factor-1
05/03/1995EP0327612B1 Pharmaceutical therapeutic use of glutathione derivatives
05/03/1995CA2134866A1 Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
05/03/1995CA2134865A1 Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals
05/03/1995CA2134630A1 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives
05/02/1995US5412145 P2'-modified hydroxamic acid collagenase inhibitors
05/02/1995US5412141 Bisphosphonic acid derivatives as anti-arthritic agents
05/02/1995US5412102 Angiotensin II receptor antagonist
05/02/1995US5412101 Sulphorous derivatives of imidazole, and their use as medicaments and the pharmaceutical compositions containing them
05/02/1995US5411991 Applying to human skin, beards, reaction with cysteine
05/02/1995US5411975 Thiazolidinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/02/1995US5411973 Therapeutic alcohols
05/02/1995US5411971 N-alkylenepiperidino compounds, their enantiomers and pharmaceutical compositions
05/02/1995US5411962 Benzomorpholinyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
05/02/1995US5411961 Benzo-fused morpholinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/02/1995US5411960 Substituted pyrroloanthracenes and -diones
05/02/1995US5411959 1,4-Thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/02/1995US5411958 Benzothiomorpholinyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
05/02/1995US5411957 3-azabicyclo[3.2.1]-nonanyl-terminated non-piptidyl alpha-succinamidoacyl aminodiols as anti-hypertensive agents
05/02/1995US5411956 Lipolytic enzyme inhibitors
05/02/1995US5411954 Benzo-fused oxazopinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/02/1995US5411953 Oxazopinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/02/1995US5411950 Benzo-fused oxazocinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/02/1995US5411941 Heterodimeric osteogenic factor
05/02/1995CA2134707A1 Methods and compositions for retarding the aging process
05/02/1995CA1335450C Indole and indazole keto sulphones as leukotriene antagonists
04/1995
04/29/1995CA2134418A1 Linear adhesion inhibitors
04/27/1995WO1995011303A1 Cntf family antagonists
04/27/1995WO1995011260A1 Process for preparing an inter-alpha-trypsine inhibitor concentrate for therapeutical use, and concentrate thus obtained
04/27/1995WO1995011259A1 Platelet-derived growth factor analogues
04/27/1995WO1995011253A1 A method for enhancing neurone survival and agents useful for same
04/27/1995WO1995011244A1 Pyridazino quinoline compounds
04/27/1995WO1995011242A1 Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compounds having retinoid like biological activity
04/27/1995WO1995011231A1 Amidino derivatives useful as nitric oxide synthase inhibitors
04/27/1995WO1995011221A1 Calcium receptor-active arylalkyl amines
04/27/1995WO1995011029A1 Combination of bisphosphonates and growth hormone secretagogues
04/27/1995WO1995011024A1 Picosulphate dosage form
04/27/1995WO1995011021A1 Use of 2-(2-alkylphenylamino)-oxazolines, -thiazolines and -imidazolines as alpha 2 adrenergic agents
04/27/1995WO1995011016A1 R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof
04/27/1995WO1995011014A1 Amidino derivatives useful as nitric oxide synthase inhibitors
04/27/1995WO1995011013A2 Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women
04/27/1995WO1995011003A1 New use of prostaglandins
04/27/1995WO1995010938A1 Oligonucleotide modulation of multidrug resistance-associated protein
04/27/1995WO1995007279A3 Process for the preparation of indolizine derivatives
04/27/1995WO1995002409A3 Use of vitamin d and derivatives thereof for the manufacture of a medicament for protection against neuron loss
04/27/1995WO1994027594A3 Stable copper(i) complexes and methods related thereto
04/27/1995DE4336051A1 1,2-Dihydro-2-oxopyridines
04/27/1995CA2174655A1 New use of prostaglandins
04/27/1995CA2174425A1 A method for enhancing neurone survival and agents useful for same
04/27/1995CA2173468A1 Amidino derivatives useful as nitric oxide synthase inhibitors
1 ... 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 ... 1564